메뉴 건너뛰기




Volumn 105, Issue 18, 2002, Pages 2212-2216

Mineralocorticoid receptor antagonism in experimental atherosclerosis

Author keywords

Atherosclerosis; Endothelium; Nitric oxide; Superoxide

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; CHOLESTEROL; EPLERENONE; MINERALOCORTICOID RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

EID: 0037035471     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000015854.60710.10     Document Type: Article
Times cited : (203)

References (12)
  • 2
    • 0033586639 scopus 로고    scopus 로고
    • Increased NADH-oxidasemediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system
    • (1999) Circulation , vol.99 , pp. 2027-2033
    • Warnholtz, A.1    Nickenig, G.2    Schulz, E.3
  • 3
    • 0034651798 scopus 로고    scopus 로고
    • Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin 1/angiotensin II conversion in patients with chronic heart failure
    • (2000) Circulation , vol.101 , pp. 594-597
    • Farquharson, C.A.1    Struthers, A.D.2
  • 4
    • 0030005713 scopus 로고    scopus 로고
    • Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
    • (1996) J Clin Invest , vol.97 , pp. 1916-1923
    • Rajagopalan, S.1    Kurz, S.2    Munzel, T.3
  • 12
    • 0034126414 scopus 로고    scopus 로고
    • Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology
    • (2000) Kidney Int , vol.57 , pp. 1408-1411
    • Delyani, J.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.